En Es
Categories

Industry News

Global AI-Based Surgical Robots Market to Reach USD 17.2 Billion by 2028

By HospiMedica International staff writers
08 Jul 2021

IllustrationThe global AI-based surgical robots market size is expected to expand at a CAGR of 17.2% from 2021 to 2028 to reach USD 17.2 billion by 2028, driven by increased efficiency and success rate offered by robotic surgeries, along with a shift in the preference for minimally invasive surgeries by patients over traditional methods.

These are the latest findings of Grand View Research, Inc. (San Francisco, CA, USA), a market research and consulting company.

Based on product, the services segment dominated the market for AI-based surgical robots and accounted for the largest revenue share of 52.0% in 2020. The high share is attributable to the higher cost of maintenance associated with the algorithms of robot-assisted surgery systems. Furthermore, routine technological upgrades and comprehensive service contracts provided to customers by many companies further increases the revenue share. However, the instruments and accessories segment is anticipated to grow at the fastest rate during the forecast period. The growth can be attributed to the rising number of surgeries, increasing preference for the product among surgeons, and surging popularity of robot-assisted surgeries over traditional surgeries. In addition, the ongoing development of new technologies and upgrades in existing instruments and accessories are contributing to the surging adoption of AI-based surgical robots. These factors, in turn, are expected to boost the market for AI-based surgical robots over the forecasted period.

Based on application, the others segment dominated the market for AI-based surgical robots and accounted for the largest revenue share of 36.9% in 2020. Other applications mainly include general surgeries, laparoscopy, and ophthalmology, and oncology surgeries. The factors contributing to the high revenue share of the segment include increasing abdominal and oncology-based surgical procedures, coupled with the rising prevalence of breast cancer. In addition, the growing adoption of robots for minimally invasive laparoscopic procedures by surgeons further contributes to the segment’s higher share. However, the neurology segment is anticipated to witness the highest CAGR over the forecast period. The highest success rate and efficiencies of the products in various neurological procedures compared to traditional methods are mainly responsible for the segment’s growth. Furthermore, the growing usage and adoption of technologically advanced robots for surgeries in health care institutions is boosting the growth of the market for AI-based surgical robots.

In addition, the pandemic of COVID-19 has also drastically impacted growth opportunities in the market for AI-based surgical robots. To curtail the spread of the virus and prioritize the treatment of COVID-19 patients, healthcare institutions across the world reduced elective surgeries that have led to a decline in any new product acquisition by any healthcare facilities. However, the trend is likely to shift towards robotic surgery procedures post-pandemic. After a decline in the magnitude of the pandemic, technologically-advanced robotic surgeries are expected to gain traction, owing to the benefits of the product, such as reduced duration of surgeries and lesser number of interactions between the patient and medical staff.

The increased penetration of advanced technologies such as AI in the field of robotic surgeries is also boosting the market growth. The growing use of AI technologies in surgical systems is owing to its advantages that range from the consolidation of databases to intra-operative video analysis which, in turn, is supporting the adoption of AI-based surgical robots. A shift in trend from traditional practices of surgical procedures to AI-based approaches by healthcare professionals is also driving the market for AI-based surgical robots. There is an upsurge in the adoption of technologically advanced robots for various applications by surgeons. The rising adoption of such products for various applications is expected to propel the growth of the market for AI-based surgical robots over the forecast period.

In 2020, North America dominated the global AI-based surgical robots market and accounted for the largest revenue share of 46.9%. The region held the largest revenue share owing to the presence of major players, increasing opportunities for start-ups to enter the market and ongoing developments in the field of AI and robotics for healthcare. In addition, the increasing demand for minimally invasive procedures and robot-assisted surgeries is fueling the market growth. However, in Asia Pacific, the market for AI-based surgical robots is expected to exhibit significant growth potential over the forecast period. The introduction of technologically advanced equipment in surgical procedures and interventional procedures in the regional segment, coupled with the increasing number of patients opting for robotic surgery, is expected to propel the market growth during the forecast period. In addition, increasing investments by major players in the Asia Pacific region is further anticipated to boost the market growth.

Related Links:
Grand View Research, Inc.



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

22 Sep 2021
Thermo Fisher Launches World’s First Fully Integrated Digital PCR (dPCR) System
Thermo Fisher Scientific Inc. (Waltham, MA, USA) has launched the world’s first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.
Read More
17 Sep 2021
44th IHF World Hospital Congress Presents Over 60 Plenary Sessions and 200 Renowned Speakers Across Four-Day Event
The 44th World Hospital Congress organized by The International Hospital Federation (Geneva, Switzerland) will bring together more than 200 healthcare experts, leading industry thinkers, and best practice presenters at over 60 sessions around nursing leadership, humanizing technology, COVID-19 vaccination, the next global pandemic, etc.
Read More
17 Sep 2021
Global Digital Polymerase Chain Reaction (dPCR) Market Projected to Reach Close to USD 1.15 Billion by 2028
 The global digital polymerase chain reaction (dPCR) market is projected to grow at a CAGR of more than 9% from over USD 0.50 billion in 2020 to nearly USD 1.15 billion by 2028, driven primarily by rising infectious diseases, technological developments, as well as increased knowledge and acceptance of tailored treatments.
Read More
15 Sep 2021
Certest Offers Sensitive, Useful and Cheap CE-IVD Multiplex Assay for Rapid Diagnosis of Atypical Pneumonia
CerTest Biotec (Zaragoza, Spain) has developed and validated the CE-IVD multiplex assay VIASURE C. pneumoniae, M. pneumoniae & L. pneumophila real time PCR kit for the detection of principal pathogens implicated in atypical pneumoniae.
Read More
15 Sep 2021
Mesa Laboratories to Acquire Molecular Diagnostics Tools Company Agena Bioscience
Mesa Laboratories, Inc. (Lakewood, CO, USA) has entered into a definitive agreement to acquire Agena Bioscience, Inc. (San Diego, CA, USA).
Read More
14 Sep 2021
Zoll Acquires Medical Device and Digital Health Company Itamar Medical
ZOLL Medical Corporation (Chelmsford, MA, USA), an Asahi Kasei company, has signed an agreement to acquire Itamar Medical Ltd. (Caesarea, Israel), a medical device and digital health company focused on the integration of sleep apnea diagnosis into the cardiac patient care pathway.
Read More
13 Sep 2021
Global Blood, Gas and Electrolyte Analyzers Market Projected to Reach Nearly USD 3.50 Billion by 2023
The global blood, gas and electrolyte analyzers market is projected to grow at a CAGR of 8.6% from more than USD 2.10 billion in 2016 to nearly USD 3.50 billion by the end of 2023, driven by rapid developments in the healthcare sector that are resulting in the implementation of technologies to help care providers and patients in treating diseases. For instance, hospitals are implementing technologies like AR and VR that can provide real-time simulation of human body that can help them understand the anomaly of patients. However, the need for blood, gas analyzers to achieve greater accuracy and the requirement of regular maintenance are expected to hinder market growth.
Read More
09 Sep 2021
Stryker Completes Acquisition of Medical Device Company Gauss Surgical
Stryker (Kalamazoo, MI, USA) has completed the acquisition of Gauss Surgical (Menlo Park, CA, USA), a medical device company that has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery.
Read More
08 Sep 2021
Global In Vitro Diagnostics (IVD) Quality Control Market Projected to Reach USD 1.4 Billion by 2026
The global in vitro diagnostics (IVD) quality control market is projected to grow at a CAGR of 5.3% from USD 1.1 billion in 2021 to USD 1.4 billion by 2026, thanks to the significant role played by IVD testing in clinical decision-making.
Read More
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions